PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Florian Lordick, J. R. Siewert, Ken Herrmann et al.|The Lancet Oncology|2007

Cited by 808